Showing results (1361-1370 of 9,123) with videos related to
Sort By:
Pageof 913
Cancer Medicine|June 28, 2020
External validation of life expectancy prognostic models in patients evaluated for palliative radiotherapy at the end-of-lifeAdrianna E Mojica-Márquez, Joshua L Rodríguez-López, Ankur K Patel, et al.Cancer Medicine|July 1, 2020
Quantitative ultrasound radiomics in predicting response to neoadjuvant chemotherapy in patients with locally advanced breast cancer: Results from multi-institutional studyDaniel DiCenzo, Karina Quiaoit, Kashuf Fatima, et al.Cancer Medicine|July 1, 2020
High mutation burden of circulating cell-free DNA in early-stage breast cancer patients is associated with a poor relapse-free survivalJouni Kujala, Jaana M Hartikainen, Maria Tengström, et al.Cancer Medicine|July 2, 2020
Multiagent therapy with pomalidomide, bortezomib, doxorubicin, dexamethasone, and daratumumab ("Pom-PAD-Dara") in relapsed/refractory multiple myelomaXiang Zhou, Maximilian J Steinhardt, Denise Grathwohl, et al.Cancer Medicine|July 2, 2020
Promising survival rate but high incidence of treatment-related mortality after reduced-dose craniospinal radiotherapy and tandem high-dose chemotherapy in patients with high-risk medulloblastomaJi Won Lee, Do Hoon Lim, Ki Woong Sung, et al.Cancer Medicine|June 26, 2020
The efficacy and safety of neoadjuvant chemotherapy on patients with advanced gastric cancer: A multicenter randomized clinical trialQun Zhao, Changhong Lian, Zhibin Huo, et al.Cancer Medicine|June 26, 2020
Trabecular bone deterioration in differentiated thyroid cancer: Impact of long-term TSH suppressive therapyFederico Hawkins Carranza, Sonsoles Guadalix Iglesias, María Luisa De Mingo Domínguez, et al.Cancer Medicine|April 18, 2015
Multicentric occurrence of multiple papillary thyroid carcinomas--HUMARA and BRAF mutation analysisTadao Nakazawa, Tetsuo Kondo, Ippei Tahara, et al.Cancer Medicine|April 10, 2021
The patient perspective in the era of personalized medicine: What about scanxiety?José A E Custers, Lucy Davis, Christina Messiou, et al.Cancer Medicine|May 15, 2023
A multicenter phase II trial of primary prophylactic PEG-rhG-CSF in pediatric patients with solid tumors and non-Hodgkin lymphoma after chemotherapy: An interim analysisJunting Huang, Suying Lu, Juan Wang, et al.Pageof 913